Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer ; volume:21 ; number:1 ; day:13 ; month:1 ; year:2021 ; pages:1-10 ; date:12.2021
BMC health services research ; 21, Heft 1 (13.1.2021), 1-10, 12.2021
- Urheber
-
Biskupiak, Joseph
Unni, Sudhir
Telford, Claire
Yoo, Minkyoung
Ye, Xiangyang
Deka, Rishi
Brixner, Diana
Stenehjem, David
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-020-06038-z
- URN
-
urn:nbn:de:101:1-2021030521003784139694
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
09.03.2026, 13:31 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Biskupiak, Joseph
- Unni, Sudhir
- Telford, Claire
- Yoo, Minkyoung
- Ye, Xiangyang
- Deka, Rishi
- Brixner, Diana
- Stenehjem, David
- SpringerLink (Online service)
Ähnliche Objekte (12)
BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer
BRCA mutations in a cohort of Iraqi patients presenting to a tertiary referral center
Clinicoepidemilogical Correlation of BRCA 1 and 2 Mutations in Carcinoma Ovary-an Indian Perspective
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis
Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer
Cancer risk assessment of premalignant breast tissues from patients with BRCA mutations by genome profiling
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
Ehlers, Carroll, charges and dual charges
BRCA-assoziierter Brustkrebs : erblicher Brustkrebs: was Sie über die BRCA Muttaion wissen müssen
BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer
BRCA mutations in a cohort of Iraqi patients presenting to a tertiary referral center
Clinicoepidemilogical Correlation of BRCA 1 and 2 Mutations in Carcinoma Ovary-an Indian Perspective
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis
Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer
Cancer risk assessment of premalignant breast tissues from patients with BRCA mutations by genome profiling
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
Ehlers, Carroll, charges and dual charges
BRCA-assoziierter Brustkrebs : erblicher Brustkrebs: was Sie über die BRCA Muttaion wissen müssen
BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer
BRCA mutations in a cohort of Iraqi patients presenting to a tertiary referral center
Clinicoepidemilogical Correlation of BRCA 1 and 2 Mutations in Carcinoma Ovary-an Indian Perspective
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis
Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer
Cancer risk assessment of premalignant breast tissues from patients with BRCA mutations by genome profiling
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
Ehlers, Carroll, charges and dual charges